Table 1 Gene expression model and protein expression model for predicting S2, S3 and S4 molecular subtypes.

From: Genomics and proteomics to determine novel molecular subtypes and predict the response to immunotherapy and the effect of bevacizumab in glioblastoma

GBM molecular subtypes

Gene Expression (TCGA)

Accuracy (%)

Protein Expression (RPPA)

Accuracy (%)

S2

C5orf38

96.7

CJUN_pS73

84.6

NPPA

CMYC

NKAIN1

CRAF_pS338

NHLH1

CYCLINB1

IRX2

DVL3

PCDH15

EGFR_pY1173

KLRC3

NOTCH1

FBN3

P38_pT180Y182

GFRA1

PKCDELTA_pS664

RASL11B

SRC

MEX3B

STATHMIN

RCOR2

VEGFR2

MDGA2

BRCA2

 

MYH11

 

TFRC

 

ANNEXIN1

 

PD-L1

S3

F13A1

86.7

GSK3ALPHABETA

38.5

CYP1B1

PAI1

COL6A3

 

IGFBP6

 

MRC1

 

IL6

 

CHRNA9

 

CAMP

 

LOX

 

SCNN1B

 

PODNL1

 

NAMPT

 

MOXD1

 

PLA2G5

 

LGALS3

 

C15orf48

 

LY96

 

S4

DMRTA2

93.3

X4EBP1_pT37T46

84.6

GAS1

X53BP1

ACSBG1

BAX

CDH4

ECADHERIN

EYA2

EEF2K

AFAP1L1

HER2_pY1248

ADGRE5

NFKBP65_pS536

LKAAEAR1

NF2

ERFE

S6_pS240S244

ETV4

SMAD1

DENND2A

SRC

CREB5

STATHMIN

ACSL3

GAPDH

CCND2

HEREGULIN

 

GATA6

 

BRD4

 

DUSP4

 

P16INK4A